Categories Earnings, Health Care

Zydus Lifescience Ltd Q4FY23 results out, revenue grows by 32%

In 1995, the group was restructured and thus was formed Cadila Healthcare under the aegis of the Zydus group. From a humble turnover Rs. 250 crores in 1995 the group witnessed a significant financial growth and registered a turnover of over Rs. 14,253 crores in FY20. Adhering to its brand promise of being dedicated to life in all its dimensions, Zydus continues to innovate with an unswerving focus to address the unmet healthcare needs. Simultaneously it rededicates itself to its mission of creating healthier, happier communities across the globe

  • Zydus Lifescience Ltd reported Total revenue for Q4 FY23 of ₹5,011 Crore, up from ₹3,806 Crore year on year depicting a growth of 32%.
  • Total Expenses for Q4 FY23 of ₹3,755 Crore up, from ₹3,088 Crore year on year, a growth of 22%. 
  • Consolidated Net Profit of ₹358 Crore, down 21% from ₹453 Crore in the same quarter of the previous year. 
  • The Earnings per Share is ₹2.93, down 24% from ₹3.88 in the same quarter of the previous year.

Most Popular

Cochin Shipyard Ltd (COCHINSHIP) Q4 FY22 Earnings Concall Transcript

Cochin Shipyard Limited (NSE:COCHINSHIP) Q4 FY22 Earnings Concall dated May. 26, 2022 Corporate Participants: Madhu S Nair -- Chairman & Managing Director Jose V J -- Director Finance Analysts: Vastupal Shah

All you need to know about Antony Waste Handling Cell in one article

Can you guess the name of the company that was listed during the IPO frenzy in 2020 and is the second largest player in the Indian municipal waste management industry?

Demystifying the Leading Non-Ferrous Recycling Company of India

“Hey, how is the market doing today?” “Oh!, its falling tremendously since morning” I am sure news like these might be a common topic of discussion for you nowadays. Interestingly,

Top